WICELL POSTERS & PUBLICATIONS
At WiCell, it is our mission to support stem cell research and the development of stem cell clinical applications worldwide. WiCell's staff frequently contributes their expertise and findings to leading publications as one of the ways we uphold our mission. Several of the articles, book contributions, and posters WiCell has presented are available below.
Please contact us with any questions regarding these publications, or to arrange a discussion with any of the contributing authors from WiCell.
Click through to view the listing of publications citing WiCell or using WiCell's products and services.
Download PDF: Reporting practices for publishing results with human PSCs and tissue stem cells
(Stem Cell Reports 18, September 12, 2023)
ISSCR standards for the use of human stem cells in basic research
(Stem Cell Reports 18, September 2023)
Enhancing reproducibility in human stem cell research
(Nature Cell Biology, August 2023)
Setting the Standards for Human Stem Cell Research
(ISSCR The Stem Cell Report Podcast, Season 3 Episode 2)
The consequences of recurrent genetic and epigenetic variants in human pluripotent stem cells
(Cell Stem Cell, December 2022)
Cytogenetic Characterization Comparison Chart
(ISSCR Digital Series: Standards for the Characterization and Use of Pluripotent Stem Cell Lines in Research: Part 1, October 2021)
G-Banded Karyotyping of Human Pluripotent Stem Cell Cultures
(Nuclear Reprogramming, Springer Protocols, p.251-268, November 2020)
A Retrospective Analysis of Cytogenetic Changes Seen in Human Pluripotent Stem Cell Cultures
(poster presented at ISSCR, June 2020)
Genomic Stability Testing of Pluripotent Stem Cells
(Current Protocols in Stem Cell Biology, March 2020)
Human pluripotent stem cell quality: A scientific wake-up call
(poster presented at ISSCR June 2019)
High-Level Gene Amplification in Human Pluripotent Stem Cells
(poster presented at ISSCR June 2019)
A report from a workshop of the International Stem cell Banking Initiative, held in collaboration GAiT and the Harvard Stem cell Institute, Boston 2017
(Stem Cell Res., December 2018)
20 Years of Human Pluripotent Stem Cell Research: It All Started with Five Lines.
(Cell Stem Cell, November 2018)
Quality control guidelines for clinical-grade human induced pluripotent stem cell lines
(Regen Med, October 2018)
Assessment of established techniques to determine developmental and malignant potential of human pluripotent stem cells
(Nature Communications, May 2018)
A Standard Nomenclature for Referencing and Authentication of Pluripotent Stem Cells
(Stem Cell Reports, January 2018)Report of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem Cells.
(Stem Cell Translational Medicine, November 2017)
Cryobanking Plutipotent Stem Cells
(Stem Cell Banking, Springer Protocols, Part of the Methods in Molecular Biology book series, 2017)
Culture, Adaptation, and Expansion of Pluripotent Stem Cells
(Stem Cell Banking, Springer Protocols, Part of the Methods in Molecular Biology book series, 2017)
Cell line resources from Parkinson's Progression Markers Initiative (PPMI) participants
(Poster, presented at ISSCR June 2017)
Relative frequencies of recurrent acquired karyotypic abnormalities in hPSC from 2009 to 2016
(Poster, presented at ISSCR June 2017)
Recurrent Duplications of the Long Arm of Chromosome 1 in Human Pluripotent Stem Cell Lines
(Poster, presented at ISSCR June 2016)
Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI)
(Regenerative Medicine, 2015)
Identifiability and privacy in pluripotent stem cell research
(Cell Stem Cell, April 2014)
Banking human induced pluripotent stem cells: lessons learned from embryonic stem cells?
(Cell Stem Cell, October 2013)
Validation of karyotypic abnormalities in human pluripotent stem cells: Cytogenetic progression in WA09 mirrors cancer
(Cancer Genetics, July-August 2012)
Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage
(Nature Biotechnology, November 2011)
Recurrent copy number variations in human induced pluripotent stem cells
(Nature Biotechnology, June 2011)
Karyotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells
(Nature Biotechnology, April 2011)
A call for standardized naming and reporting of human ESC and iPSC lines.
(Cell Stem Cell, April 2011)
Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy
(PNAS 2011)
Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells.
(Blood, February 2011) [Epub ahead of print]
DNA methylation assay for X-chromosome inactivation in female human iPS cells
(Stem Cell Reviews and Reports, 2011)
Automation in an array comparative genomic hybridization laboratory improves throughput and data quality.
(JALA, 2010)
Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells.
(In Vitro Cellular & Developmental Biology Animal, April 2010)
Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes.
(Stem Cell Reviews, December 2009)
International banking: checks, deposits, and withdrawals.
(Cell Stem Cell, April 2008)
